Villatoro A, Dougé A, Krpina K, Schmitz LM, Forcados C, Kaveh F, Arias-Díaz AE, Gelebart P, McCormack E, Stripecke R, Abal M, Davidson B, Inderberg EM, Wälchli S (2026)
Combining TAG-72CAR with anti-MUC16CAR improves the potency of ovarian cancer treatment
FEBS J (in press)
DOI 10.1111/febs.70760, PubMed 42834815

Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2026)
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Mol Ther (in press)
DOI 10.1016/j.ymthe.2026.09.027, PubMed 42800469

Gondaliya P, Zinn DA, Sayyed AA, Driscoll J, Yan IK, Mensali N, Wälchli S, Patel T (2026)
Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells
Mol Pharm, 23 (9), 4540-4552
DOI 10.1021/acs.molpharmaceut.6c00219, PubMed 42704135